Lucrezia Ciotti The growing use of GLP-1-based weight-loss drugs, such as tirzepatide and semaglutide, is attracting attention not only for their weight-loss effects but also for their potential side effects. Recent confessions, including that of the singer Robbie Williams, highlight sudden difficulties that raise questions.
Robbie Williams: Physical and mental well-being under the spotlight
Despite the concerns, Robbie Williams He acknowledges the benefits of treatment on his mental and physical health. The drug has allowed him to overcome years of "constant anguish" and regain a regular wellness routine. Every day, he dedicates himself to stretching, strength and mobility exercises, including lunges, push-ups, squats, and core workouts, with the goal of soon being able to do pull-ups. The pop star emphasizes that his experience he doesn't want to demonize these drugs, but raise awareness of the possible consequences.
In parallel, the growing popularity of Mounjaro, Ozempic and Wegovy – initially intended for type 2 diabetes and obesity – has brought to light the importance of conscious use, as, although effective in controlling appetite and weight, they can cause rare but potentially serious side effects.
Robbie Williams' Drama: "I'm Losing My Sight Due to a Weight-Loss Drug"
During an American football game, Robbie Williams perceived something unusual: the players on the field appeared as “green spots on a green background”. Initially he thought it was a normal age-related decline in vision, but he soon realized that the problem It was more serious. When he consulted an ophthalmologist, he discovered that his prescription had changed significantly, forcing him to replace his glasses. Despite this, the visual difficulties persisted, even making it difficult for him to see the audience during concerts.My vision is blurry, it's getting worse”, he confessed to The Sun, stressing that he continued to use slimming injections despite being aware of the risks.
The artist attributes the eye problems to GLP-1 drugs, such as tirzepatide and semaglutide, and invites those who use them to obtain further information:
"It is important to do your research before starting any such weight loss program.".
Health authorities in several countries are monitoring rare cases of optic nerve neuropathy linked to these treatments, but there is still no scientific consensus on a direct cause-effect relationship.